Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268786 · ClinicalTrials.gov registry record · NA
Single Embryo TrAnsfeR of Euploid Embryo
A NA study, sponsored by Illumina.
- Completed
- Registry status
- NA
- Development phase
- 661
- Enrollment target
NCT02268786: Completed NA study, sponsored by Illumina.
NCT02268786 is a NA study that has completed, run by Illumina. The registered enrollment target is 661 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02268786, a NA study, has completed, sponsored by Illumina.
- COMPLETED
- Registry status
- NA
- Development phase
- 661 participants
- Enrollment target
Study Summary
The purpose of the current study is to evaluate the effect of preimplantation genetic screening (PGS) by next generation sequencing (NGS) compared to standard morphological assessment of embryos on pregnancy rates through a randomized controlled trial (RCT). All embryos will be vitrified and a single embryo transfer (SET) will be performed with either screened or unscreened embryos depending on randomization.
Primary Outcome
Number of Participants with Ongoing Pregnancy at 20 Weeks Gestation
Interventions
- OTHER Preimplantation Genetic Screening by NGS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 661 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
What the finished NCT02268786 record still lists
NCT02268786 is an interventional study that assigns participants to a tested intervention. The registered 661 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Preimplantation Genetic Screening by NGS is the first listed.
NCT02268786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02268786 about?
NCT02268786 is a clinical study titled "Single Embryo TrAnsfeR of Euploid Embryo". The purpose of the current study is to evaluate the effect of preimplantation genetic screening (PGS) by next generation sequencing (NGS) compared to standard morphological assessment of embryos on pregnancy rates through a randomized controlled trial (RCT). All embryos will be vitrified and a singl...
What is the current status of trial NCT02268786?
This trial is currently completed. It is a NA study. The enrollment target is 661 participants. The study started on 2014-09. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02268786?
The interventions under investigation include: Preimplantation Genetic Screening by NGS (OTHER).
Who is sponsoring clinical trial NCT02268786?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02268786's enrollment target sits among peer trials
661 155th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05254743 · 662 participants · Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia